Global Myasthenia Gravis Therapies Market Size, Status and Forecast 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 97

Report ID: 4190

Myasthenia gravis is a chronic autoimmune neuromuscular disease that causes weakness in the skeletal muscles, which are responsible for breathing and moving parts of the body, including the arms and legs.
In 2018, the global Myasthenia Gravis Therapies market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Myasthenia Gravis Therapies status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Myasthenia Gravis Therapies development in United States, Europe and China.

The key players covered in this study
Alexion Pharmaceuticals
Novartis
CSL Behring
Grifols
...

Market segment by Type, the product can be split into
Ocular Myasthenia Gravis
Congenital Myasthenia Gravis
Generalized Myasthenia Gravis
Transient Myasthenia Gravis
Others

Market segment by Application, split into
Hospitals and Clinics
Diagnostic Centers
Academic and Research Organizations

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Myasthenia Gravis Therapies status, future forecast, growth opportunity, key market and key players.
To present the Myasthenia Gravis Therapies development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Myasthenia Gravis Therapies are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Myasthenia Gravis Therapies Market Size Growth Rate by Type (2014-2025)
1.4.2 Ocular Myasthenia Gravis
1.4.3 Congenital Myasthenia Gravis
1.4.4 Generalized Myasthenia Gravis
1.4.5 Transient Myasthenia Gravis
1.4.6 Others
1.5 Market by Application
1.5.1 Global Myasthenia Gravis Therapies Market Share by Application (2014-2025)
1.5.2 Hospitals and Clinics
1.5.3 Diagnostic Centers
1.5.4 Academic and Research Organizations
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Myasthenia Gravis Therapies Market Size
2.2 Myasthenia Gravis Therapies Growth Trends by Regions
2.2.1 Myasthenia Gravis Therapies Market Size by Regions (2014-2025)
2.2.2 Myasthenia Gravis Therapies Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Myasthenia Gravis Therapies Market Size by Manufacturers
3.1.1 Global Myasthenia Gravis Therapies Revenue by Manufacturers (2014-2019)
3.1.2 Global Myasthenia Gravis Therapies Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Myasthenia Gravis Therapies Market Concentration Ratio (CR5 and HHI)
3.2 Myasthenia Gravis Therapies Key Players Head office and Area Served
3.3 Key Players Myasthenia Gravis Therapies Product/Solution/Service
3.4 Date of Enter into Myasthenia Gravis Therapies Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Myasthenia Gravis Therapies Market Size by Type (2014-2019)
4.2 Global Myasthenia Gravis Therapies Market Size by Application (2014-2019)

5 United States
5.1 United States Myasthenia Gravis Therapies Market Size (2014-2019)
5.2 Myasthenia Gravis Therapies Key Players in United States
5.3 United States Myasthenia Gravis Therapies Market Size by Type
5.4 United States Myasthenia Gravis Therapies Market Size by Application

6 Europe
6.1 Europe Myasthenia Gravis Therapies Market Size (2014-2019)
6.2 Myasthenia Gravis Therapies Key Players in Europe
6.3 Europe Myasthenia Gravis Therapies Market Size by Type
6.4 Europe Myasthenia Gravis Therapies Market Size by Application

7 China
7.1 China Myasthenia Gravis Therapies Market Size (2014-2019)
7.2 Myasthenia Gravis Therapies Key Players in China
7.3 China Myasthenia Gravis Therapies Market Size by Type
7.4 China Myasthenia Gravis Therapies Market Size by Application

8 Japan
8.1 Japan Myasthenia Gravis Therapies Market Size (2014-2019)
8.2 Myasthenia Gravis Therapies Key Players in Japan
8.3 Japan Myasthenia Gravis Therapies Market Size by Type
8.4 Japan Myasthenia Gravis Therapies Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Myasthenia Gravis Therapies Market Size (2014-2019)
9.2 Myasthenia Gravis Therapies Key Players in Southeast Asia
9.3 Southeast Asia Myasthenia Gravis Therapies Market Size by Type
9.4 Southeast Asia Myasthenia Gravis Therapies Market Size by Application

10 India
10.1 India Myasthenia Gravis Therapies Market Size (2014-2019)
10.2 Myasthenia Gravis Therapies Key Players in India
10.3 India Myasthenia Gravis Therapies Market Size by Type
10.4 India Myasthenia Gravis Therapies Market Size by Application

11 Central & South America
11.1 Central & South America Myasthenia Gravis Therapies Market Size (2014-2019)
11.2 Myasthenia Gravis Therapies Key Players in Central & South America
11.3 Central & South America Myasthenia Gravis Therapies Market Size by Type
11.4 Central & South America Myasthenia Gravis Therapies Market Size by Application

12 International Players Profiles
12.1 Alexion Pharmaceuticals
12.1.1 Alexion Pharmaceuticals Company Details
12.1.2 Company Description and Business Overview
12.1.3 Myasthenia Gravis Therapies Introduction
12.1.4 Alexion Pharmaceuticals Revenue in Myasthenia Gravis Therapies Business (2014-2019)
12.1.5 Alexion Pharmaceuticals Recent Development
12.2 Novartis
12.2.1 Novartis Company Details
12.2.2 Company Description and Business Overview
12.2.3 Myasthenia Gravis Therapies Introduction
12.2.4 Novartis Revenue in Myasthenia Gravis Therapies Business (2014-2019)
12.2.5 Novartis Recent Development
12.3 CSL Behring
12.3.1 CSL Behring Company Details
12.3.2 Company Description and Business Overview
12.3.3 Myasthenia Gravis Therapies Introduction
12.3.4 CSL Behring Revenue in Myasthenia Gravis Therapies Business (2014-2019)
12.3.5 CSL Behring Recent Development
12.4 Grifols
12.4.1 Grifols Company Details
12.4.2 Company Description and Business Overview
12.4.3 Myasthenia Gravis Therapies Introduction
12.4.4 Grifols Revenue in Myasthenia Gravis Therapies Business (2014-2019)
12.4.5 Grifols Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details